Agios Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $1.24B
Liabilities Breakdown FY2022
Total Liabilities: $137.9M
Asset Breakdown
Total Assets: $1.24B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $139.3M | 11.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $8.5M | 0.7% |
| Property, Plant & Equipment | $23.0M | 1.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.07B | 86.2% |
Liabilities Breakdown
Total Liabilities: $137.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $18.6M | 13.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $119.3M | 86.5% |